The impact of HPV vaccine disinformation and misinformation in disadvantaged educational settings in Ireland: A multi-year analysis of a school immunisation system
Allison Deane , Christine White , Yvonne Morrissey , Lucy Jessop , Suzanne Cotter , Lois O. Connor , Vicky McKenna , Aishwarya Vivekkumar , Tony Fitzgerald , Chantal Migone
{"title":"The impact of HPV vaccine disinformation and misinformation in disadvantaged educational settings in Ireland: A multi-year analysis of a school immunisation system","authors":"Allison Deane , Christine White , Yvonne Morrissey , Lucy Jessop , Suzanne Cotter , Lois O. Connor , Vicky McKenna , Aishwarya Vivekkumar , Tony Fitzgerald , Chantal Migone","doi":"10.1016/j.vaccine.2025.126868","DOIUrl":null,"url":null,"abstract":"<div><h3>Purpose</h3><div>Introduced in 2010, Ireland's school-based HPV immunisation programme has shown lower vaccine uptake in disadvantaged DEIS (Delivering Equality of Opportunity in Schools) schools compared to non-DEIS schools. This study aims to determine if the HPV vaccine misinformation period (2015–2017) disproportionately affected DEIS schools.</div></div><div><h3>Methods</h3><div>This is a register-based cohort study that used routinely collected data on HPV vaccination uptake in girls only, combined with DEIS status from the Department of Education. The analysis covered six academic years (2013–2019), focusing on three periods: 1) Prior to vaccine misinformation (academic years 2013–2014/2014–2015), 2) During misinformation (academic years 2015–2016/2016–2017), and 3) Recovery (academic years 2017–2018/2018–2019).</div></div><div><h3>Results</h3><div>Overall HPV vaccination uptake was 84.8 % before the misinformation, dropped to 55.2 % during the misinformation, and increased to 72.9 % during the recovery period. The uptake difference between DEIS and non-DEIS schools was 4.5 % (95 % CI 1.80–7.17) before the misinformation, 8.0 % (95 % CI 5.35–10.68) during misinformation, and 12.4 % (95 % CI 9.80–14.91) in the recovery period, with DEIS schools showing reduced recovery compared to non-DEIS schools (64.5 % vs 76.5 %; <em>p</em> < 0.001).</div></div><div><h3>Conclusion</h3><div>HPV vaccine misinformation disproportionately affected HPV vaccine uptake in disadvantaged schools. Tailored interventions are needed to address this disparity in DEIS schools.</div></div>","PeriodicalId":23491,"journal":{"name":"Vaccine","volume":"51 ","pages":"Article 126868"},"PeriodicalIF":4.5000,"publicationDate":"2025-02-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Vaccine","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0264410X25001653","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Purpose
Introduced in 2010, Ireland's school-based HPV immunisation programme has shown lower vaccine uptake in disadvantaged DEIS (Delivering Equality of Opportunity in Schools) schools compared to non-DEIS schools. This study aims to determine if the HPV vaccine misinformation period (2015–2017) disproportionately affected DEIS schools.
Methods
This is a register-based cohort study that used routinely collected data on HPV vaccination uptake in girls only, combined with DEIS status from the Department of Education. The analysis covered six academic years (2013–2019), focusing on three periods: 1) Prior to vaccine misinformation (academic years 2013–2014/2014–2015), 2) During misinformation (academic years 2015–2016/2016–2017), and 3) Recovery (academic years 2017–2018/2018–2019).
Results
Overall HPV vaccination uptake was 84.8 % before the misinformation, dropped to 55.2 % during the misinformation, and increased to 72.9 % during the recovery period. The uptake difference between DEIS and non-DEIS schools was 4.5 % (95 % CI 1.80–7.17) before the misinformation, 8.0 % (95 % CI 5.35–10.68) during misinformation, and 12.4 % (95 % CI 9.80–14.91) in the recovery period, with DEIS schools showing reduced recovery compared to non-DEIS schools (64.5 % vs 76.5 %; p < 0.001).
Conclusion
HPV vaccine misinformation disproportionately affected HPV vaccine uptake in disadvantaged schools. Tailored interventions are needed to address this disparity in DEIS schools.
目的:爱尔兰2010年推出的校本HPV免疫规划显示,与非校本学校相比,处境不利的DEIS(在学校提供机会平等)学校的疫苗接种率较低。本研究旨在确定HPV疫苗错误信息期(2015-2017)是否不成比例地影响DEIS学校。方法:这是一项基于登记的队列研究,使用常规收集的仅女孩接种HPV疫苗的数据,并结合教育部的DEIS状况。该分析涵盖了六个学年(2013-2019),重点关注三个时期:1)疫苗错误信息之前(2013-2014/2014-2015学年),2)错误信息期间(2015-2016/2016-2017学年),3)恢复(2017-2018/2018-2019学年)。结果误传前HPV疫苗接种率为84.8%,误传期间接种率降至55.2%,恢复期间接种率上升至72.9%。DEIS学校与非DEIS学校之间的吸收差异在错误信息之前为4.5% (95% CI 1.80-7.17),在错误信息期间为8.0% (95% CI 5.35-10.68),在恢复期为12.4% (95% CI 9.80-14.91),与非DEIS学校相比,DEIS学校的恢复程度较低(64.5%对76.5%;p & lt;0.001)。结论HPV疫苗错误信息对弱势学校HPV疫苗接种率的影响不成比例。需要有针对性的干预措施来解决DEIS学校的这种差异。
期刊介绍:
Vaccine is unique in publishing the highest quality science across all disciplines relevant to the field of vaccinology - all original article submissions across basic and clinical research, vaccine manufacturing, history, public policy, behavioral science and ethics, social sciences, safety, and many other related areas are welcomed. The submission categories as given in the Guide for Authors indicate where we receive the most papers. Papers outside these major areas are also welcome and authors are encouraged to contact us with specific questions.